The markets opened mixed with the Dow losing 25 points to 20,498 while Nasdaq gained 33 points to 5,882 as investors monitored earnings news.
On the upside
Soligenix (Nasdaq: SNGS) will present results from its ricin toxin vaccine development program at the 20th Annual Conference on Vaccine Research on April 25.
Ultragenyx Pharmaceutical (Nasdaq: RARE) reported positive results from a Phase 3 study of burosumab to treat X-linked hypophosphatemia.
Lam Research (Nasdaq: LRCX) reported sharply higher third quarter earnings that beat analyst expectations.
On the downside
Sunshine Heart (Nasdaq: SSH) priced its public offering of common stocks and warrants at the discounted price of $1.00 per unit.
International Business Machines (NYSE: IBM) disappointed with lower fourth quarter revenue that fell short of expectations.
Investors locked in profits on Interpace Diagnostics Group (Nasdaq: IDXG).
In the broad market, advancing issues outpaced decliners by a margin of 5 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 index gained 6 points to 2,348. Bitcoin held steady at $1206.